Labs like Full Spectrum and Steep Hill are springing up to serve the medical marijuana dispensaries and patients in states like Colorado and California to test the strength and purity of the drug.
Prices have been dropping nationwide over the past three to four years, with medical marijuana states like Oregon and Montana home to the lowest prices.
The legalization of medical marijuana in several states has paved the way for a budding edible medical marijuana industry. Small businesses in states such as Colorado and California are making treats such as candy, cookies or soda.
Despite the declaration that the “ingredients are there” for a deal between Genzyme Corp and Sanofi-Aventis but at a higher price, consensus among investors seem to be that Sanofi won’t be raising their bid of $69/share
Weight-loss surgery, once a last resort for extremely overweight people, may soon become an option for those who are less heavy.
The jobless rate barely budges, more finance pros head to China and vocational schools become more popular.
Dixie Elixirs makes a line of pot-infused drinks and eats that it sells to medical centers in Colorado.
One of every seven Medicare beneficiaries who is hospitalized is harmed as a result of problems with the medical care there, according to a new study from the Office of Inspector General for the Department of Health and Human Services. The New York Times reports.
In writing, "Health care is mentioned every 20 seconds in one form of media or another. There’s little debate that something must to be done about the ever-rising health care costs; the point of contention is the what," one author offers his company's prescription.
The insurers have begun tightening oversight of the care provided to patients with many different types of cancer, hoping to lower expenses by experimenting with new ways to pay specialists. The NYT reports.
As earnings season intensifies, so will scrutiny over Johnson & Johnson when it reports results on Tuesday.
Pfizer says it has agreed to buy King Pharmaceuticals for $3.6 billion in cash.
See what's happening, who's talking and what will be making headlines on Tuesday's Squawk on the Street.
The first oral treatment for multiple sclerosis could generate $1 billion in sales, the CEO of Novartis, its manufacturer, told CNBC Thursday.
Next September, the first-ever United Nations summit on non-communicable diseases will be held. It is a prime opportunity to elevate chronic disease on the global agenda. And it’s a life or death decision for the world’s human and economic health.
See what's happening, who's talking and what will be making headlines on Friday's Squawk on the Street.
In a snapshot of systemic waste, researchers have calculated that more than half of the 354 million doctor visits made each year for acute medical care, like for fevers, stomachaches and coughs, are not with a patient’s primary physician, and that more than a quarter take place in hospital emergency rooms. The NYT reports.
President Obama faces a messy political fight over the federal court ruling striking down his new, looser policy letting federal grant money pay for stem cell research involving “destroyed” embryos.
Why the “Mad Money” host has faith in this pharmacy-benefit manager, even though the market may not.
Medical tourism, family travel and international migration have combined to import a potent new form of antibiotic resistance halfway around the planet—and the physician-researchers who have tracked its rapid spread say it is already on the verge of becoming untreatable.